Creating advanced software for brain imaging to improve neuropsychiatric treatment
Official title: Design and Development of an Advanced Functional MRI Software as Medical Device (SaMD) forClinical Trials and Therapeutic Applications in Neuropsychiatry
Funded at Ceretype Neuromedicine in · NIH-11069492 · Data updated 2026-11-12
This study is working on a new software to make brain scans more accurate and reliable, which could help doctors better understand how treatments for conditions like depression and anxiety are working, ultimately leading to improved care for patients.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ceretype Neuromedicine in NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | April 3, 2025 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $380,375 |
| NIH project number | 1R44MH136867-01A1 |
| Project ID | NIH-11069492 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with neuropsychiatric disorders who are participating in clinical trials for new therapies.
✕Less likely to help
Patients with neuropsychiatric conditions who are not involved in clinical trials or those who do not meet specific eligibility criteria for the imaging studies may not benefit from this research.
What this research studies
This research focuses on developing a new software platform for functional magnetic resonance imaging (fMRI) that aims to enhance the accuracy and reliability of brain imaging in clinical trials for neuropsychiatric conditions. By addressing current limitations in fMRI technology, such as artifacts and reproducibility issues, the project seeks to provide clearer insights into how treatments affect the brain. This could lead to better understanding and validation of therapies for conditions like depression and anxiety, ultimately improving patient outcomes. The approach involves advanced techniques like multi-echo fMRI and independent component analysis to boost the quality of imaging data.
Why it matters
Potential benefit: If successful, this research could lead to more effective neuropsychiatric treatments by providing clearer evidence of how therapies impact brain function.
How similar studies have gone: Previous research has shown that advancements in fMRI technology can significantly improve the understanding of brain function and treatment effects, indicating a promising potential for this novel approach.
Where this research is happening
-
Ceretype Neuromedicine in
Cambridge, United States Active
Researchers
- Principal investigator: Stern, Emily — Ceretype Neuromedicine in
- Study coordinator: Stern, Emily
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.